Trial Profile
The role of Bosentan in fontan patients: improvement of aerobic capacity.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 14 May 2009
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Congenital heart defects
- Focus Therapeutic Use
- 14 May 2009 New trial record